LAVA Therapeutics NV (LAVA Therapeutics NV) Additional Paid-In Capital : $194.42 Mil(As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Additional Paid-In Capital?

LAVA Therapeutics NV's quarterly additional paid-in capital stayed the same from Jun. 2023 ($194.42 Mil) to Sep. 2023 ($194.42 Mil) and stayed the same from Sep. 2023 ($194.42 Mil) to Dec. 2023 ($194.42 Mil).

LAVA Therapeutics NV's annual additional paid-in capital increased from Dec. 2021 ($192.27 Mil) to Dec. 2022 ($194.42 Mil) but then stayed the same from Dec. 2022 ($194.42 Mil) to Dec. 2023 ($194.42 Mil).

LAVA Therapeutics NV Additional Paid-In Capital Historical Data

The historical data trend for LAVA Therapeutics NV's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Additional Paid-In Capital Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

19.56

41.09

192.27

194.42

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial												194.42	194.42	194.42	194.42	194.42

LAVA Therapeutics NV Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

LAVA Therapeutics NV Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.